Protein Therapeutics Market Research Report by Protein Function (Enzymatic and Regulatory, Protein Diagnostics, and Vaccines), by Product Type (Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, and Insulin) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Protein Therapeutics Market is expected to grow from USD 63,177.70 Million in 2020 to USD 88,085.88 Million by the end of 2025.
2. The Global Protein Therapeutics Market is expected to grow from EUR 55,395.41 Million in 2020 to EUR 77,235.37 Million by the end of 2025.
3. The Global Protein Therapeutics Market is expected to grow from GBP 49,246.64 Million in 2020 to GBP 68,662.41 Million by the end of 2025.
4. The Global Protein Therapeutics Market is expected to grow from JPY 6,742,662.45 Million in 2020 to JPY 9,400,996.00 Million by the end of 2025.
5. The Global Protein Therapeutics Market is expected to grow from AUD 91,742.43 Million in 2020 to AUD 127,912.42 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Protein Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Protein Function, the Protein Therapeutics Market studied across Enzymatic and Regulatory, Protein Diagnostics, and Vaccines.
Based on Product Type, the Protein Therapeutics Market studied across Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, and Monoclonal Antibodies.
Based on Geography, the Protein Therapeutics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Protein Therapeutics Market including Ambrx, Aravive, AstraZeneca PLC, Atomwise, Autolus, DesigneRx Pharmaceuticals, Editas Medicine, F. Hoffmann-La Roche AG, Genentech, Good Therapeutics, Institut Pasteur, LabGenius, Leiden University Medical, LGC Group, Morphic Therapeutic, Omeros, Pfizer, ProteinQure, Sanofi S.A., SilkTech Biopharmaceuticals, Translate Bio, Trinity College Dublin, and Venturis Therapeutics.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Protein Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Protein Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Protein Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Protein Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Protein Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Protein Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Protein Therapeutics Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Protein Therapeutics Market is expected to grow from USD 63,177.70 Million in 2020 to USD 88,085.88 Million by the end of 2025.
2. The Global Protein Therapeutics Market is expected to grow from EUR 55,395.41 Million in 2020 to EUR 77,235.37 Million by the end of 2025.
3. The Global Protein Therapeutics Market is expected to grow from GBP 49,246.64 Million in 2020 to GBP 68,662.41 Million by the end of 2025.
4. The Global Protein Therapeutics Market is expected to grow from JPY 6,742,662.45 Million in 2020 to JPY 9,400,996.00 Million by the end of 2025.
5. The Global Protein Therapeutics Market is expected to grow from AUD 91,742.43 Million in 2020 to AUD 127,912.42 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Protein Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Protein Function, the Protein Therapeutics Market studied across Enzymatic and Regulatory, Protein Diagnostics, and Vaccines.
Based on Product Type, the Protein Therapeutics Market studied across Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, and Monoclonal Antibodies.
Based on Geography, the Protein Therapeutics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Protein Therapeutics Market including Ambrx, Aravive, AstraZeneca PLC, Atomwise, Autolus, DesigneRx Pharmaceuticals, Editas Medicine, F. Hoffmann-La Roche AG, Genentech, Good Therapeutics, Institut Pasteur, LabGenius, Leiden University Medical, LGC Group, Morphic Therapeutic, Omeros, Pfizer, ProteinQure, Sanofi S.A., SilkTech Biopharmaceuticals, Translate Bio, Trinity College Dublin, and Venturis Therapeutics.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Protein Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Protein Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Protein Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Protein Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Protein Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Protein Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Protein Therapeutics Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Protein Function Outlook
3.4. Product Type Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing healthcare expenditure in the emerging markets
5.1.1.2. Government initiatives to improve the healthcare services
5.1.1.3. Growing geriatric population & rising predominance of chronic diseases
5.1.2. Restraints
5.1.3. Opportunities
5.1.3.1. Potential for bispecific monoclonal antibodies
5.1.3.2. Unmet medical needs in developing countries
5.1.4. Challenges
5.1.4.1. High cost of production and treatment
5.1.4.2. Competition from biosimilars
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PROTEIN THERAPEUTICS MARKET, BY PROTEIN FUNCTION
6.1. Introduction
6.2. Enzymatic and Regulatory
6.3. Protein Diagnostics
6.4. Vaccines
7. GLOBAL PROTEIN THERAPEUTICS MARKET, BY PRODUCT TYPE
7.1. Introduction
7.2. Blood Clotting Factor
7.3. Erythropoietin
7.4. Follicle Stimulating Hormone
7.5. G-CSF
7.6. Insulin
7.7. Interferons
7.8. Monoclonal Antibodies
8. AMERICAS PROTEIN THERAPEUTICS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Ambrx
12.2. Aravive
12.3. AstraZeneca PLC
12.4. Atomwise
12.5. Autolus
12.6. DesigneRx Pharmaceuticals
12.7. Editas Medicine
12.8. F. Hoffmann-La Roche AG
12.9. Genentech
12.10. Good Therapeutics
12.11. Institut Pasteur
12.12. LabGenius
12.13. Leiden University Medical
12.14. LGC Group
12.15. Morphic Therapeutic
12.16. Omeros
12.17. Pfizer
12.18. ProteinQure
12.19. Sanofi S.A.
12.20. SilkTech Biopharmaceuticals
12.21. Translate Bio
12.22. Trinity College Dublin
12.23. Venturis Therapeutics
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Protein Function Outlook
3.4. Product Type Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing healthcare expenditure in the emerging markets
5.1.1.2. Government initiatives to improve the healthcare services
5.1.1.3. Growing geriatric population & rising predominance of chronic diseases
5.1.2. Restraints
5.1.3. Opportunities
5.1.3.1. Potential for bispecific monoclonal antibodies
5.1.3.2. Unmet medical needs in developing countries
5.1.4. Challenges
5.1.4.1. High cost of production and treatment
5.1.4.2. Competition from biosimilars
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PROTEIN THERAPEUTICS MARKET, BY PROTEIN FUNCTION
6.1. Introduction
6.2. Enzymatic and Regulatory
6.3. Protein Diagnostics
6.4. Vaccines
7. GLOBAL PROTEIN THERAPEUTICS MARKET, BY PRODUCT TYPE
7.1. Introduction
7.2. Blood Clotting Factor
7.3. Erythropoietin
7.4. Follicle Stimulating Hormone
7.5. G-CSF
7.6. Insulin
7.7. Interferons
7.8. Monoclonal Antibodies
8. AMERICAS PROTEIN THERAPEUTICS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Ambrx
12.2. Aravive
12.3. AstraZeneca PLC
12.4. Atomwise
12.5. Autolus
12.6. DesigneRx Pharmaceuticals
12.7. Editas Medicine
12.8. F. Hoffmann-La Roche AG
12.9. Genentech
12.10. Good Therapeutics
12.11. Institut Pasteur
12.12. LabGenius
12.13. Leiden University Medical
12.14. LGC Group
12.15. Morphic Therapeutic
12.16. Omeros
12.17. Pfizer
12.18. ProteinQure
12.19. Sanofi S.A.
12.20. SilkTech Biopharmaceuticals
12.21. Translate Bio
12.22. Trinity College Dublin
12.23. Venturis Therapeutics
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GLOBAL PROTEIN THERAPEUTICS MARKET: SCORES
TABLE 76. GLOBAL PROTEIN THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 77. GLOBAL PROTEIN THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 78. GLOBAL PROTEIN THERAPEUTICS MARKET: RANKING
TABLE 79. GLOBAL PROTEIN THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 80. GLOBAL PROTEIN THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 81. GLOBAL PROTEIN THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 82. GLOBAL PROTEIN THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 83. GLOBAL PROTEIN THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 84. GLOBAL PROTEIN THERAPEUTICS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GLOBAL PROTEIN THERAPEUTICS MARKET: SCORES
TABLE 76. GLOBAL PROTEIN THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 77. GLOBAL PROTEIN THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 78. GLOBAL PROTEIN THERAPEUTICS MARKET: RANKING
TABLE 79. GLOBAL PROTEIN THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 80. GLOBAL PROTEIN THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 81. GLOBAL PROTEIN THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 82. GLOBAL PROTEIN THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 83. GLOBAL PROTEIN THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 84. GLOBAL PROTEIN THERAPEUTICS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL PROTEIN THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PROTEIN THERAPEUTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2020 (USD MILLION)
FIGURE 5. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL PROTEIN THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL PROTEIN THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2020 VS 2025 (%)
FIGURE 14. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2025
FIGURE 16. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2025 (%)
FIGURE 20. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025
FIGURE 22. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2020 VS 2025 (USD MILLION)
FIGURE 29. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 30. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 32. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 38. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 40. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 52. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. GLOBAL PROTEIN THERAPEUTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 64. GLOBAL PROTEIN THERAPEUTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 65. GLOBAL PROTEIN THERAPEUTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PROTEIN THERAPEUTICS MARKET, BY TYPE
FIGURE 1. GLOBAL PROTEIN THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PROTEIN THERAPEUTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2020 (USD MILLION)
FIGURE 5. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL PROTEIN THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL PROTEIN THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2020 VS 2025 (%)
FIGURE 14. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2025
FIGURE 16. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC AND REGULATORY, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2025 (%)
FIGURE 20. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025
FIGURE 22. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2020 VS 2025 (USD MILLION)
FIGURE 29. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 30. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 32. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 38. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 40. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 52. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. GLOBAL PROTEIN THERAPEUTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 64. GLOBAL PROTEIN THERAPEUTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 65. GLOBAL PROTEIN THERAPEUTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PROTEIN THERAPEUTICS MARKET, BY TYPE
